67
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Therapeutic effects of physostigmine during systemic inflammation

, , &
Pages 465-475 | Published online: 07 Dec 2018

References

  • BrunkhorstFMEpidemiology, economy and practice – results of the German study on prevalence by the competence network sepsis (SepNet)Anasthesiol Intensivmed Notfallmed Schmerzther2006411434416440262
  • TrampuzAZimmerliWPathogenesis und therapie der sepsisSchweiz Med Forum200335811818
  • VincentJLSerranoECDimoulaACurrent management of sepsis in critically ill adult patientsExpert Rev Anti Infect Ther20119784785621810056
  • RhodesAEvansLEAlhazzaniWSurviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016Intensive Care Med201743330437728101605
  • SeymourCWLiuVXIwashynaTJAssessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)JAMA2016315876277426903335
  • Poli-de-FigueiredoLFGarridoAGNakagawaNSannomiyaPExperimental models of sepsis and their clinical relevanceShock200830Suppl 1535918704008
  • RemickDGWardPAEvaluation of endotoxin models for the study of sepsisShock200524Suppl 171116374366
  • Effenberger-NeidnichtKAl NatorMBrencherLOude LansinkMde GrootHPrevention of endotoxin-induced hypotension in rats by the circadian hormone melatoninInfection201341S11S12
  • ZhaoBMoochhalaSMThamSYBiologically active components of Physostigma venenosumJ Chromatogr B Analyt Technol Biomed Life Sci20048121–2183192
  • KalbAvon HaefenCSifringerMAcetylcholinesterase inhibitors reduce neuroinflammation and -degeneration in the cortex and hippocampus of a surgery stress rat modelPLoS One201385e6267923671623
  • BettenDPVohraRBCookMDMatteucciMJClarkRFAntidote use in the critically ill poisoned patientJ Intensive Care Med200621525527716946442
  • StilsonMKellyKSuchardJPhysostigmine as an antidoteCal J Emerg Med200124474820852697
  • ZielmannSPetrowHWaltherPHenzeTIntensive care of delirium syndromesAnaesthesiol Reanim200328181212666506
  • NilssonEMeretojaOANeuvonenPHemodynamic responses to physostigmine in patients with a drug overdoseAnesth Analg198362108858886614520
  • PeterCSchmidtKHoferSEffects of physostigmine on microcirculatory alterations during experimental endotoxemiaShock201033440541120407407
  • HoferSEisenbachCLukicIKPharmacologic cholinesterase inhibition improves survival in experimental sepsisCrit Care Med200836240440818091537
  • ZhouJPavlovicDRübJPhysostigmine reverses disturbances of the intestinal microcirculation during experimental endotoxemiaClin Hemorheol Microcirc201456327328423736080
  • ZunićGSavićJProstranMVaragićVVujnovSTodorovićZThe effect of physostigmine on acid-base status in arterial and venous blood of anaesthetized rabbits following hypovolemic shockGen Pharmacol19952622912957590076
  • SavićJVaragićVMProkićDThe life-saving effect of physostigmine in haemorrhagic shockResuscitation199121157601852065
  • GuariniSTagliaviniSFerrariWBertoliniAReversal of haemorrhagic shock in rats by cholinomimetic drugsBr J Pharmacol19899812182242804546
  • MathisKWSulzerJMolinaPESystemic administration of a centrally acting acetylcholinesterase inhibitor improves outcome from hemorrhagic shock during acute alcohol intoxicationShock201034216216820023599
  • Effenberger-NeidnichtKBrencherLBroecker-PreussMHamburgerTPetratFde GrootHImmune stimulation by exogenous melatonin during experimental endotoxemiaInflammation201437373874424385237
  • PetratFSwobodaSde GrootHSchmitzKJQuantification of ischemia-reperfusion injury to the small intestine using a macroscopic scoreJ Invest Surg201023420821720690846
  • VerhaeghRPetratFde GrootHAttenuation of intestinal ischemic injury and shock by physostigmineJ Surg Res2015194240541425483738
  • ScreminOUScreminAMPhysostigmine induced reversal of ischemia following acute middle cerebral artery occlusion in the ratStroke1986175100410093764945
  • KutsunaSTsurutaRFujitaMCholinergic agonist physostigmine suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in rats with forebrain ischemia/reperfusionBrain Res2010131324224919968973
  • ZimmermannJBPinderNBrucknerTAdjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se)Trials201718153029126416
  • BernikTRFriedmanSGOchaniMCholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusionJ Vasc Surg20023661231123612469056
  • PavlovVAWangHCzuraCJFriedmanSGTraceyKJThe cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulationMol Med200395–812513414571320
  • TraceyKJPhysiology and immunology of the cholinergic antiinflammatory pathwayJ Clin Invest2007117228929617273548
  • FodaleVSantamariaLBCholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathwayCrit Care Med200836262262318216614
  • SulzerJKMolinaPEDelayed resuscitation with physostigmine increases end organ damage in alcohol intoxicated ratsShock2011351747920577152
  • HoffmanJRMcelroyCRBicarbonate therapy for dysrhythmia and hypotension in tricyclic antidepressant overdoseWest J Med1981134160646259839
  • EndouMTanitoYOkumuraFA comparison between chronotropic effects of neostigmine and edrophonium in isolated guinea pig right atriumJ Pharmacol Exp Ther19972823148014869316862
  • SchultzJAHoffmanWEAlbrechtRFSympathetic stimulation with physostigmine worsens outcome from incomplete brain ischemia in ratsAnesthesiology19937911141218102038
  • AkinciSBUluNYondemOZEffect of neostigmine on organ injury in murine endotoxemia: missing facts about the cholinergic antiinflammatory pathwayWorld J Surg200529111483148916222449
  • SpitzerJJMyocardial metabolism during acute shock induced by hemorrhage, endotoxin, or physostigmine infusionMyocardial Metabolism19743161167